Skip to main content
U.S. flag

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Find more clinical trials

Innovations in Dementia Empowerment and Action

Start: December 5, 2018
End: May 2023
Enrollment: 225

What Is This Study About?

This study will compare two behavioral interventions for lesbian, gay, bisexual, and transgender (LGBT) individuals with Alzheimer's disease or a related dementia and their caregivers. Reducing Disability in Alzheimer's Disease (RDAD) has been used to train individuals with Alzheimer's disease or a related dementia and their caregivers to better manage behavioral symptoms. Researchers will compare RDAD to a similar intervention that addresses LGBT-specific risk factors, including identity management, stigma-related adverse/traumatic life events, and lack of social support. The training involves nine 60-minute, virtual sessions over six weeks, plus four 15-minute, follow-up phone sessions over four months. The program focuses on increasing physical activities of individuals with Alzheimer's and their caregivers and learning to cope with the behavioral components of dementia. Researchers will look at the interventions' effects on behavioral symptoms, physical activity levels, caregiver stress, and quality of life.

Do I Qualify To Participate in This Study?

Minimum Age: 50 Years

Maximum Age: N/A

Must have:

Participants with Dementia

  • Dementia (e.g., Alzheimer's disease, mild cognitive impairment, vascular dementia, Parkinson's disease, Lewy body dementia) or memory loss significant enough to affect daily activities 

Caregivers

  • Unpaid caregiver
  • Willing to commit to 30 minutes each day for study activities or coordinate daily activities for the care recipient

All Participants

  • Either the caregiver and/or dementia care recipient must self-identify as LGBT (or sexual or gender non-binary or same-sex sexual behavior)
  • Living in the community, not in a care facility
  • Living in the United States

Must NOT have:

  • Known terminal illness (with death anticipated within the next 12 months)
  • Hospitalization for a psychiatric disorder in the past 12 months
  • Currently suicidal or having major hallucinations or delusions
  • Plans to move to long-term care setting within six months of study enrollment
  • Any physical limitations or chronic conditions preventing participation in an exercise program

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

 

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: University of Washington

Source: ClinicalTrials.gov ID: NCT03550131

 

alzheimers.gov

An official website of the U.S. government, managed by the National Institutes on Aging at the National Institutes of Health